Target intelligence / Profile preview

Ribosomal protein L18a pseudogene 14 (RPL18AP14)

Target: RPL18AP14
Molecular classification: Other (pseudogene)

Overview

Ribosomal protein L18a pseudogene 14 (RPL18AP14) is a processed pseudogene in the human genome, derived from the ribosomal protein L18a gene[5][8]. Pseudogenes like RPL18AP14 do not encode functional proteins and typically arise through gene duplication or retrotransposition events. While some pseudogenes have regulatory roles or may contribute to gene expression regulation, no specific biological function or disease association has been reported for RPL18AP14[5][8]. It is included in genomic databases for annotation purposes but is not considered a drug target, biomarker, or therapeutic entity.

Other names: RPL18A_9_1800RPL18AP14

Beyond the preview

Go deeper on Ribosomal protein L18a pseudogene 14 (RPL18AP14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L18a pseudogene 14 (RPL18AP14).

Explore the full profile